Alnylam and Collaborators Publish new Pre-clinical Research on Therapeutic Silencing of Parkinson's Disease Gene 31 August 2010 New Research shows silencing of alpha-synuclein in the Substantia Nigra of non-human primates with an RNAi therapeutic.
Marina Biotech Announces Issuance of a U.S. Patent Broadly Covering its Amphoteric Liposomal siRNA Delivery Technology 25 August 2010 Patent further strengthens Marina Biotech's RNA delivery intellectual property portfolio.
The Porcine microRNAome is Revealed 23 August 2010 Results blaze a trail for advancement in pig biology as well the use of pigs as model organism for human biological and biomedical studies.
Quark and Novartis Enter into Licensing Option Agreement for the p53 Suppressor Drug QPI-1002 20 August 2010 Novartis gains an exclusive worldwide license to develop and commercialize the p53 temporary inhibitor siRNA drug for $10 million.
Bioo Scientific Chooses Eureka Genomics as its Next-Generation Sequencing Provider 19 August 2010 Bioo Scientific chose Eureka Genomics based on their extensive sequencing experience, quick turnaround times and strong bioinformatics support.
Scientists Uncover Achilles Heel of Chronic Inflammatory Pain 19 August 2010 BBSRC funded discovery could lead to a brand new class of drugs to treat chronic pain caused by inflammatory conditions.
In NIH-Funded Study, Researchers Uncover Early Step in the Cascade of Brain Events Leading up to Addiction 17 August 2010 Findings represent additional clues to help predict vulnerability to drug abuse.
Parent Project Muscular Dystrophy Awards $600K to Nationwide Children's Hospital for Gene Therapy Study 16 August 2010 Dr. Jerry Mendell to lead follistatin gene therapy for Duchenne muscular dystrophy.